163 related articles for article (PubMed ID: 33765889)
1. Osmotic demyelination syndrome in patients with non-Hodgkin lymphoma: a case report and literature review.
García-Grimshaw M; Jiménez-Ruiz A; Ruiz-Sandoval JL; Cantú-Brito C; Chiquete E
Int J Neurosci; 2023 Mar; 133(3):233-237. PubMed ID: 33765889
[TBL] [Abstract][Full Text] [Related]
2. Osmotic demyelination syndrome caused by rapid correction of hyperammonemia and continuous hyperbilirubinemia: a case report and review of the literature.
Park K; Kim SB; Yoon SS; Woo HG
Encephalitis; 2023 Oct; 3(4):119-124. PubMed ID: 37797653
[TBL] [Abstract][Full Text] [Related]
3. A novel association of osmotic demyelination in Sjögren's syndrome prompts revisiting role of aquaporins in CNS demyelinating diseases: A literature review.
Sandhya P; Akaishi T; Fujihara K; Aoki M
Mult Scler Relat Disord; 2023 Jan; 69():104466. PubMed ID: 36584554
[TBL] [Abstract][Full Text] [Related]
4. Osmotic demyelination syndrome following correction of hyponatremia: association with hypokalemia.
Lohr JW
Am J Med; 1994 May; 96(5):408-13. PubMed ID: 8192171
[TBL] [Abstract][Full Text] [Related]
5. [Osmotic demyelination syndrome in patients with hyponatremia caused by neurologic disorders].
Jiang Y; Wei JJ; Wang RZ; Ren ZY
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2011 Dec; 33(6):696-700. PubMed ID: 22509558
[TBL] [Abstract][Full Text] [Related]
6. Osmotic Demyelination Syndrome following Correction of Hyponatremia by ≤10 mEq/L per Day.
Tandukar S; Sterns RH; Rondon-Berrios H
Kidney360; 2021 Sep; 2(9):1415-1423. PubMed ID: 35373113
[TBL] [Abstract][Full Text] [Related]
7. Osmotic demyelination syndrome improving after immune-modulating treatment: Case report and literature review.
Kalampokini S; Artemiadis A; Zis P; Hadjihannas L; Parpas G; Kyrri A; Hadjigeorgiou GM
Clin Neurol Neurosurg; 2021 Sep; 208():106811. PubMed ID: 34358802
[TBL] [Abstract][Full Text] [Related]
8. Role of Risk Factors in Developing Osmotic Demyelination Syndrome During Correction of Hyponatremia: A Case Study.
Reijnders TDY; Janssen WMT; Niamut SML; Kramer AB
Cureus; 2020 Jan; 12(1):e6547. PubMed ID: 32042522
[TBL] [Abstract][Full Text] [Related]
9. Osmotic demyelination syndrome following acute kidney injury with hypernatremia.
Alkali NH; Jibrin YB; Dunga JA; Abdu A
Niger J Clin Pract; 2019 Aug; 22(8):1166-1168. PubMed ID: 31417063
[TBL] [Abstract][Full Text] [Related]
10. Ultrastructural Analysis of Thalamus Damages in a Mouse Model of Osmotic-Induced Demyelination.
Bouchat J; Gilloteaux J; Suain V; Van Vlaender D; Brion JP; Nicaise C
Neurotox Res; 2019 Jul; 36(1):144-162. PubMed ID: 31049881
[TBL] [Abstract][Full Text] [Related]
11. Isolated extrapontine myelinolysis of osmotic demyelination syndrome.
Yilmaz O; Armagn HH; Turan A; Duymuş M
Prague Med Rep; 2013; 114(1):35-8. PubMed ID: 23547724
[TBL] [Abstract][Full Text] [Related]
12. Incidence of osmotic demyelination syndrome in Sweden: A nationwide study.
Aegisdottir H; Cooray C; Wirdefeldt K; Piehl F; Sveinsson O
Acta Neurol Scand; 2019 Nov; 140(5):342-349. PubMed ID: 31343728
[TBL] [Abstract][Full Text] [Related]
13. Severe osmotic demyelination syndrome with cortical involvement in the context of severe hyponatremia and central diabetes insipidus: an uncommon presentation of an unusual combination.
Giglio A; Reccius A; Ferre A; Dreyse J
BMJ Case Rep; 2024 Jan; 17(1):. PubMed ID: 38171637
[TBL] [Abstract][Full Text] [Related]
14. Atypical forms of the osmotic demyelination syndrome.
Ruiz-Sandoval JL; Chiquete E; Alvarez-Palazuelos LE; Andrade-Ramos MA; Rodríguez-Rubio LR
Acta Neurol Belg; 2013 Mar; 113(1):19-23. PubMed ID: 22815090
[TBL] [Abstract][Full Text] [Related]
15. Plasma exchange as treatment for osmotic demyelination syndrome: Case report and review of current literature.
Nelson NR; Tompkins MG; Thompson Bastin ML
Transfus Apher Sci; 2019 Dec; 58(6):102663. PubMed ID: 31759898
[TBL] [Abstract][Full Text] [Related]
16. Osmotic demyelination syndrome: novel risk factors and proposed pathophysiology.
Ambati R; Kho LK; Prentice D; Thompson A
Intern Med J; 2023 Jul; 53(7):1154-1162. PubMed ID: 35717664
[TBL] [Abstract][Full Text] [Related]
17. Regional oligodendrocytopathy and astrocytopathy precede myelin loss and blood-brain barrier disruption in a murine model of osmotic demyelination syndrome.
Bouchat J; Couturier B; Marneffe C; Gankam-Kengne F; Balau B; De Swert K; Brion JP; Poncelet L; Gilloteaux J; Nicaise C
Glia; 2018 Mar; 66(3):606-622. PubMed ID: 29168586
[TBL] [Abstract][Full Text] [Related]
18. Correction of hyponatremia and osmotic demyelinating syndrome: have we neglected to think intracellularly?
Pham PM; Pham PA; Pham SV; Pham PT; Pham PT; Pham PC
Clin Exp Nephrol; 2015 Jun; 19(3):489-95. PubMed ID: 25150510
[TBL] [Abstract][Full Text] [Related]
19. Prevention of the Osmotic Demyelination Syndrome After Liver Transplantation: A Multidisciplinary Perspective.
Crismale JF; Meliambro KA; DeMaria S; Bronster DB; Florman S; Schiano TD
Am J Transplant; 2017 Oct; 17(10):2537-2545. PubMed ID: 28422408
[TBL] [Abstract][Full Text] [Related]
20. Extrapontine Myelinolysis and Reversible Parkinsonism After Hyponatremia Correction in a Case of Pituitary Adenoma: Hypopituitarism as a Predisposition for Osmotic Demyelination.
Perikal PJ; Jagannatha AT; Khanapure KS; Furtado SV; Joshi KC; Hegde AS
World Neurosurg; 2018 Oct; 118():304-310. PubMed ID: 30055367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
